China (Mainland)
Vismodegib CAS NO.879085-55-9
- Min.Order: 1 Gram
- Payment Terms: L/C,T/T,Other
- Product Details
Keywords
- Imatinib drugs, treatment of basal cell carcinoma
- Vismodegib
Quick Details
- ProName: Vismodegib
- CasNo: 879085-55-9
- Molecular Formula: C19H14Cl2N2O3S
- Appearance: White Powder
- Application: Vismodegib (trade name Erivedge) is a ...
- DeliveryTime: Min 3 Days
- PackAge: Bag
- Port: Chengdu
- ProductionCapacity: 5 Metric Ton/Day
- Purity: 99.0%
- Storage: In Cool Place
- Transportation: Air
- LimitNum: 1 Gram
Superiority
Vismodegib(tradenameErivedge)isadrugforthetreatmentofbasal-cellcarcinoma(BCC).TheapprovalofvismodegibonJanuary30,2012,representsthefirst
Details
Vismodegib (trade name Erivedge) is a drug for the treatment of basal-cell carcinoma (BCC). The approval of vismodegib on January 30, 2012, represents the first Hedgehog signaling pathway targeting agent to gain U.S. Food and Drug Administration (FDA) approval.[1] The drug is also undergoing clinical trials for metastatic colorectal cancer, small-cell lung cancer, advanced stomach cancer, pancreatic cancer, medulloblastomachondrosarcoma as of June 2011.[2] The drug was developed by the biotechnology / pharmaceutical company
